TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
186
|
256
|
267 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
0
|
14
|
49 |
| EBITDA |
3
|
17
|
49 |
| Total assets |
160
|
192
|
138 |
| Current assets |
143
|
156
|
120 |
| Current liabilities |
42
|
67
|
23 |
| Equity capital |
118
|
124
|
115 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.8%
|
64.6%
|
83.3% |
| Turnover per employee |
93
|
85
|
89 |
| Profit as a percentage of turnover |
0%
|
5.5%
|
18.4% |
| Return on assets (ROA) |
0.6%
|
7.3%
|
35.5% |
| Current ratio |
340.5%
|
232.8%
|
521.7% |
| Return on equity (ROE) |
0%
|
11.3%
|
42.6% |
| Change turnover |
-61
|
-11
|
27 |
| Change turnover % |
-25%
|
-4%
|
11% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-33%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.